CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QPRC's Revenue Growth by Quarter and Year

Quest Patent Research's Revenue results by quarter and year




QPRC Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December 0.00 - 0.07 0.18
III Quarter September 0.01 0.58 0.71 0.15
II Quarter June 6.21 0.64 0.33 0.06
I Quarter March 0.86 0.02 0.16 0.12
FY   7.08 1.24 1.27 0.51



QPRC Revenue forth quarter 2018 Y/Y Growth Comment
Quest Patent Research Corp in the forth quarter achieved Revenue of $ 0.00 millions compare to recorded in same quarter a year ago.

Looking into forth quarter results within Biotechnology & Drugs industry 57 other companies have achieved higher Revenue growth. While Quest Patent Research Corp' s Revenue no change of % ranks overall at the positon no. 2539 in the forth quarter.




QPRC Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - -61.11 % -48.57 %
III Quarter September -98.28 % -18.31 % 373.33 % -54.55 %
II Quarter June 870.31 % 93.94 % 450 % 0 %
I Quarter March 4200 % -87.5 % 33.33 % -42.86 %
FY   470.97 % -2.36 % 149.02 % -

Financial Statements
Quest Patent Research's forth quarter 2018 Revenue $ 0.00 millions QPRC's Income Statement
Quest Patent Research's forth quarter 2017 Revenue $ 0.00 millions Quarterly QPRC's Income Statement
New: More QPRC's historic Revenue Growth >>


QPRC Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December -99.99 % - -90.14 % 20 %
III Quarter September -99.84 % -9.38 % 115.15 % 150 %
II Quarter June 622.09 % 3100 % 106.25 % -50 %
I Quarter March - -71.43 % -11.11 % -65.71 %
FY (Year on Year)   470.97 % -2.36 % 149.02 % -




Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #58
Healthcare Sector #323
Overall #2539

Revenue Y/Y Growth Statistics
High Average Low
269.61 % 38.5 % -68.59 %
(March 31, 2014)   (March 31, 2016)
Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #58
Healthcare Sector #323
Overall #2539
Revenue Y/Y Growth Statistics
High Average Low
269.61 % 38.5 % -68.59 %
(March 31, 2014)   (March 31, 2016)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Quest Patent Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QPRC's IV. Quarter Q/Q Revenue Comment
Recent results of 0.00 millions by Quest Patent Research Corp appear even more unfavourable if you take a look at 0.01 millions in the previous quarter.

Within Biotechnology & Drugs industry Quest Patent Research Corp achieved highest sequential Revenue growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QPRC's IV. Quarter Q/Q Revenue Comment
IV. Quarter 2018 results of 0.00 millions by Quest Patent Research Corp look even worse compare to the 0.01 millions in the previous quarter.

Within Biotechnology & Drugs industry Quest Patent Research Corp achieved highest sequential Revenue growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is .


Quest Patent Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Revenue 12 Months Ending $ 7.07 $ 7.07 $ 7.64 $ 2.07 $ 1.23
Y / Y Revenue Growth (TTM) 473.95 % 442.61 % 434.07 % 84.96 % -2.58 %
Year on Year Revenue Growth Overall Ranking # 46 # 66 # 52 # 253 # 46
Seqeuential Revenue Change (TTM) -0.04 % -7.48 % 268.68 % 68.32 % -5.49 %
Seq. Revenue Growth (TTM) Overall Ranking # 2539 # 3564 # 21 # 68 # 2545




Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 473.95% year on year, to $ 7 millions if the fiscal year would have ended in Dec 31 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 163.52% and higher than 442.61% growth in Sep 30 2018.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 46, from total ranking in previous quarter at 66.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
38.5 %
-68.59 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 58
Healthcare Sector # 17
Overall # 46

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
163.52 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 323
S&P 500 # 2539
Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 473.95% year on year, to $ 7 millions if the fiscal year would have ended in Dec 31 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 163.52% and higher than 442.61% growth in Sep 30 2018.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 46, from total ranking in previous quarter at 66.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
38.5 %
-68.59 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 58
Healthcare Sector # 17
Overall # 46

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
163.52 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 58
Sector # 323
S&P 500 # 2539




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QPRC's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QPRC's Competitors
Revenue Growth for Quest Patent Research's Suppliers
Revenue Growth for QPRC's Customers

You may also want to know
QPRC's Annual Growth Rates QPRC's Profitability Ratios QPRC's Asset Turnover Ratio QPRC's Dividend Growth
QPRC's Roe QPRC's Valuation Ratios QPRC's Financial Strength Ratios QPRC's Dividend Payout Ratio
QPRC's Roa QPRC's Inventory Turnover Ratio QPRC's Growth Rates QPRC's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2018
Petmed Express Inc -0.07 %$ -0.070 millions
Zimmer Biomet Holdings, Inc. -0.16 %$ -0.159 millions
Tg Therapeutics, Inc. -0.25 %$ -0.249 millions
Bio-rad Laboratories, Inc. -0.58 %$ -0.578 millions
Healthcare Services Group Inc -0.60 %$ -0.601 millions
Biomarin Pharmaceutical Inc -1.42 %$ -1.421 millions
Inspiremd, Inc. -1.44 %$ -1.439 millions
Prophase Labs, Inc. -1.47 %$ -1.470 millions
Meridian Bioscience Inc -1.54 %$ -1.536 millions
Capital Senior Living Corp -1.60 %$ -1.601 millions
Hca Healthcare, Inc. -1.78 %$ -1.784 millions
Bausch Health Companies Inc. -1.94 %$ -1.942 millions
Mylan N.v. -2.08 %$ -2.077 millions
Opiant Pharmaceuticals, Inc. -2.21 %$ -2.211 millions
Htg Molecular Diagnostics, Inc -2.23 %$ -2.227 millions
Invacare Corporation -2.31 %$ -2.307 millions
Gilead Sciences Inc -2.59 %$ -2.589 millions
Diversicare Healthcare Services, Inc. -3.26 %$ -3.258 millions
Encision Inc -3.33 %$ -3.326 millions
Orasure Technologies Inc -3.43 %$ -3.425 millions
Alphatec Holdings, Inc. -3.58 %$ -3.576 millions
Stereotaxis, Inc. -3.81 %$ -3.806 millions
Sophiris Bio Inc. -3.85 %$ -3.846 millions
Utah Medical Products Inc -4.36 %$ -4.362 millions
Cutera Inc -4.54 %$ -4.541 millions
Quest Diagnostics Inc -5.01 %$ -5.010 millions
Myos Rens Technology Inc. -5.10 %$ -5.096 millions
Allergan Plc -5.70 %$ -5.696 millions
American Bio Medica Corp -5.76 %$ -5.757 millions
American Shared Hospital Services -6.18 %$ -6.176 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INLX's Profile

Stock Price

INLX's Financials

Business Description

Fundamentals

Charts & Quotes

INLX's News

Suppliers

INLX's Competitors

Customers & Markets

Economic Indicators

INLX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071